Bruce M Halpryn
Directeur Général chez Eikonoklastes Therapeutics, Inc.
Postes actifs de Bruce M Halpryn
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Eikonoklastes Therapeutics, Inc.
 Eikonoklastes Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Eikonoklastes Therapeutics, Inc. provides pharmaceutical services. It develops a state of the art immune conjugate technology targeting tissue factor for the treatment of solid tumors and other pathologic conditions. The company was founded by Zhiwei Hu and is headquartered in Cincinnati, OH. | Directeur Général | 01/03/2019 | - |
| Président | 01/03/2019 | - | |
| Fondateur | 01/03/2019 | - |
Historique de carrière de Bruce M Halpryn
Anciens postes connus de Bruce M Halpryn
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Myonexus Therapeutics, Inc.
 Myonexus Therapeutics, Inc. BiotechnologyHealth Technology Myonexus Therapeutics, Inc. operates as a clinical stage company. It engages in the research and development of limb-girdle muscular dystrophy gene treatments. The company was founded by Michael Triplett and Bruce Halpryn in February 2017 and is headquartered in New Albany, OH. | Directeur/Membre du Conseil | 01/02/2017 | 01/04/2024 |
| Directeur des opérations | 01/02/2017 | 01/04/2024 | |
| Fondateur | 01/02/2017 | 01/04/2024 | |
| Secrétaire Général | 01/02/2017 | 01/04/2024 |
Statistiques
Internationale
| Etats-Unis | 3 |
Opérationnelle
| Founder | 2 |
| Director/Board Member | 1 |
| Chief Operating Officer | 1 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Myonexus Therapeutics, Inc.
Myonexus Therapeutics, Inc. BiotechnologyHealth Technology Myonexus Therapeutics, Inc. operates as a clinical stage company. It engages in the research and development of limb-girdle muscular dystrophy gene treatments. The company was founded by Michael Triplett and Bruce Halpryn in February 2017 and is headquartered in New Albany, OH. | Health Technology |
Eikonoklastes Therapeutics, Inc.
Eikonoklastes Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Eikonoklastes Therapeutics, Inc. provides pharmaceutical services. It develops a state of the art immune conjugate technology targeting tissue factor for the treatment of solid tumors and other pathologic conditions. The company was founded by Zhiwei Hu and is headquartered in Cincinnati, OH. | Health Technology |
- Bourse
- Insiders
- Bruce M Halpryn
- Expérience
